Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2005
08/10/2005EP1560832A1 Pyrimido 4,5-d pyrimidine derivatives with anticancer activity
08/10/2005EP1560831A1 Novel amino-substituted dihydropyrimido [4,5-d] pyrimidin one derivatives, their manufacture and use as pharmaceutical agents
08/10/2005EP1560830A2 Derivatives of [6, 7 - dihydro - 5h - imidazo [1,2 - a] imidazole - 3 - sulfonylamino]- propionamide and their use as inhibitors upon the interaction of cams and leukointegrins
08/10/2005EP1560829A1 Pyrimido compounds having antiproliferative activity (ii)
08/10/2005EP1560828A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands
08/10/2005EP1560827A1 Anti-infective agents
08/10/2005EP1560821A2 Antibacterial agents
08/10/2005EP1560818A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
08/10/2005EP1560817A1 Methods and compositions of novel triazine compounds
08/10/2005EP1560816A1 Quinazoline derivatives
08/10/2005EP1560812A1 Aminocyclohexyl ether compounds and uses thereof
08/10/2005EP1560630A2 7h-dibenzo[b,g][1,5]dioxocin-5-one derivatives and use thereof
08/10/2005EP1560598A1 Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity
08/10/2005EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
08/10/2005EP1560588A2 Treatment for traumatic synovitis and damaged articular cartilage
08/10/2005EP1560587A1 Cholesterol efflux and uses thereof
08/10/2005EP1560586A1 The use of an anti-allergy agent and a steroid to treat allergic rhinitis
08/10/2005EP1560585A1 Dosage form that is safeguarded from abuse
08/10/2005EP1560584A2 Fab i inhibitors
08/10/2005EP1560583A2 Histone deacetylase inhibitors for the treatment of ocular neovascular or edematous disorders and diseases
08/10/2005EP1560582A2 AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE
08/10/2005EP1560581A1 Oromucosal formulation and process for preparing the same
08/10/2005EP1560579A1 Cholesterol absorption inhibitors for the treatment of autoimmune disorders
08/10/2005EP1560578A1 Use of the distrontium salt of the acid 2- n,n-di(carboxymethyl)amino]-3-cyano-4-carboxymethyl-thiophene-5-carboxylate for the production of medicaments for the treatment of gastro-duodenal pain
08/10/2005EP1560577A2 Pharmaceutical compositions and methods of using taxane derivatives
08/10/2005EP1560576A2 Synthesis of oligomeric epicatechin and catechin-derived procyanidins
08/10/2005EP1560575A1 3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof
08/10/2005EP1560574A2 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
08/10/2005EP1560573A2 Therapeutic agents and corresponding treatments
08/10/2005EP1560572A1 Topical parasiticide formulations and methods of treatment
08/10/2005EP1560569A1 Gastro-retentive levodopa delivery form
08/10/2005EP1560568A1 Controlled release pharmaceutical compositions containing sodium alginate and sodium calcium alginate
08/10/2005EP1560567A1 Inhalation compositions with high drug ratios
08/10/2005EP1560566A1 Controlled and continued delivery of rifaximin and/or other substances
08/10/2005EP1560562A2 Dermastick thickened ointment
08/10/2005EP1560543A2 Implantable medical devices using zinc
08/10/2005EP1560503A2 Soluble isoflavone compositions
08/10/2005EP1560488A2 Antibacterial agents
08/10/2005EP1515956A4 Peptide deformylase inhibitors
08/10/2005EP1507514A4 Controlled release compositions of estradiol metabolites
08/10/2005EP1471919B1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
08/10/2005EP1461457A4 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness
08/10/2005EP1451166B1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
08/10/2005EP1399406B1 Novel estrogen receptor ligands and methods i
08/10/2005EP1395599B1 Anti-tumour anthracycline glycoside 14-sulfonic acid derivatives
08/10/2005EP1395265A4 Combretastatin a-3 prodrug
08/10/2005EP1392674B1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
08/10/2005EP1385552A4 Oral delivery method and composition for solid medications or dietary supplements
08/10/2005EP1377588B1 4-beta-1''-[(2''-(substituted benzoyl)anilino] podophyllotoxin analogues useful as anticancer agents
08/10/2005EP1368340B1 Piperazine derivatives as melanocortin receptor agonists
08/10/2005EP1358187B1 Naphthyridine derivatives
08/10/2005EP1358168B1 Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors
08/10/2005EP1357936A4 BIOCATALYTIC AND BIOMIMETIC GENERATION OF NITRIC OXIDE i IN SITU /i AT SUBSTRATE/BLOOD INTERFACES
08/10/2005EP1345946B1 Macroheterocylic compounds useful as kinase inhibitors
08/10/2005EP1343826B1 Polysaccharide compound having immune stimulating activity
08/10/2005EP1341788B1 Pyrazolopyridines
08/10/2005EP1339679B1 3-arylindole derivatives and their use as cb2 receptor agonists
08/10/2005EP1331931B1 Treatment of tinnitus
08/10/2005EP1324760A4 Creatine ester pronutrient compounds and formulations
08/10/2005EP1301207B1 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin
08/10/2005EP1299114B1 Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
08/10/2005EP1292581B1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
08/10/2005EP1282447A4 Stable polymeric micelle-type drug composition and method for the preparation thereof
08/10/2005EP1228028B1 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders
08/10/2005EP1208103B1 Reverse-turn mimetics and methods relating thereto
08/10/2005EP1194425B1 Substituted benzimidazole
08/10/2005EP1169441B8 Pharmaceutical compositions for the treatment of heart failure
08/10/2005EP1157002B1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
08/10/2005EP1098891B1 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments
08/10/2005EP1089710B1 Injectable pharmaceutical formulations of partricin derivatives
08/10/2005EP1086093B1 Tetrahydroquinoline derivatives as glycine antagonists
08/10/2005EP1075262B1 Desmethylpantoprazole compositions and methods
08/10/2005EP1069900B1 Use of reboxetine for the treatment of neuropsychiatric disorders
08/10/2005EP1003898B1 Integrin-targeting vectors having transfection activity
08/10/2005EP0957903B1 Diols of norbornene and norbornane compounds for treating pigmentation disorders, neurodegenerative diseases or proliferative skin disorders
08/10/2005EP0954284B1 Solid lipid compositions of lipophilic compounds for enhanced oral bioavailability
08/10/2005EP0927036B9 Transdermal therapeutical approach involving a combination of bisphosphate containing oestriol
08/10/2005EP0914150B1 Recombinant neospora antigens and their uses
08/10/2005EP0894009B1 Improved vision through photodynamic therapy of the eye
08/10/2005EP0888301B1 Mcbi analogs of cc-1065 and the duocarmycins
08/10/2005EP0833622B1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
08/10/2005EP0794797B1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides
08/10/2005CN2715753Y Combined transdermal cream for treating male impotence and premature ejaculation
08/10/2005CN1653125A Amelioration of the development of cataracts and other ophthalmic diseases
08/10/2005CN1653089A Organic medicine and betacyclodextrin derivative and preparation process thereof
08/10/2005CN1653083A Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation
08/10/2005CN1653082A Platinum complexes having antitumor activity
08/10/2005CN1653080A Lymphatic and blood endothelial cell genes
08/10/2005CN1653077A Nucleoside derivatives for treating hepatitis C virus infection
08/10/2005CN1653076A An antimicrobial agent
08/10/2005CN1653075A C-aryl glucoside SGLT2 inhibitors and method
08/10/2005CN1653073A Substituted phenylacetic acids
08/10/2005CN1653072A Broad -spectrum cephem compounds
08/10/2005CN1653070A Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase
08/10/2005CN1653069A R-enantiomers of pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease
08/10/2005CN1653068A Novel diazabicyclic biaryl derivatives
08/10/2005CN1653067A Carbazole derivatives and their use as NPY5 receptor antagonists
08/10/2005CN1653066A Non-nucleoside reverse transcriptase inhibitors
08/10/2005CN1653064A Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
08/10/2005CN1653063A (S)-4-amino-5-chloro-2-methoxy-N-[1-[1-(2-tetrahydrofurylcarbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, and method for producing the same, pharmaceutical composition containing the same and i
1 ... 4585 4586 4587 4588 4589 4590 4591 4592 4593 4594 4595 4596 4597 4598 4599 4600 4601 4602 4603 4604 4605 ... 7860